![Chad Winters](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermögen: 518 941 $ am 31.07.2026
Chad R.
Winters is currently Chief Accounting Officer & VP-Finance at West Pharmaceutical Services, Inc. since 2024.
Former positions include Director at La Causa, Inc. and Controller, Senior VP-Finance & Accounting at Amneal Intermediate, Inc. Education includes an undergraduate degree from Villanova University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 27.04.2026 | 1 522 ( 0 % ) | 518 941 $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| WEST PHARMACEUTICAL SERVICES, INC. | Comptroller/Controller/Auditor | 01.10.2019 |
| Unternehmen | Position | Ende |
|---|---|---|
Amneal Intermediate, Inc.
 Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Comptroller/Controller/Auditor | - |
La Causa, Inc.
 La Causa, Inc. Services to the Health IndustryHealth Services Provides social services | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
West Pharmaceutical Services, Inc.
 West Pharmaceutical Services, Inc. Medical SpecialtiesHealth Technology Manufactures and markets pharmaceuticals, biologics, vaccines & consumer healthcare products | Health Technology |
Villanova University
 Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
La Causa, Inc.
La Causa, Inc. Services to the Health IndustryHealth Services Provides social services | Health Services |
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
